Pulmatrix (PULM) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.36, -3.55% vs the prior close of $1.41.
- Volume 14.39K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PULM slides 3.5% to $1.36, a 1-month low. Closed at $1.36, -3.55% vs the prior close of $1.41. Day range $1.35–$1.48, opened at $1.42.
PULM daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — PULM slides 3.5% to $1.36, a 1-month low
- Closed at $1.36, -3.55% vs the prior close of $1.41. Day range $1.35–$1.48, opened at $1.42.
- Volume was 14.39K shares, 0.5x its 50-day average of 26.71K — lighter than usual.
- Price is -9.8% vs its 50-day average ($1.51) and -22.4% vs its 200-day average ($1.75).
- 52-week range $1.16–$5.24; today's close sits at 5% of that range, 74.0% below the 52-week high.
Oct 15, 2026 — PULM rises 2.9% to $1.41
- Closed at $1.41, +2.92% vs the prior close of $1.37. Day range $1.34–$1.49, opened at $1.36.
- Volume was 22.10K shares, 0.8x its 50-day average of 26.34K.
- Price is -6.9% vs its 50-day average ($1.51) and -19.7% vs its 200-day average ($1.76).
- 52-week range $1.16–$5.24; today's close sits at 6% of that range, 73.1% below the 52-week high.
Oct 14, 2026 — PULM dips 0.7% to $1.37, a 1-month low, 4 down days in a row
- Closed at $1.37, -0.72% vs the prior close of $1.38. Day range $1.35–$1.39, opened at $1.36.
- Volume was 10.00K shares, 0.4x its 50-day average of 26.49K — lighter than usual.
- Price is -9.8% vs its 50-day average ($1.52) and -22.2% vs its 200-day average ($1.76).
- 52-week range $1.16–$5.24; today's close sits at 5% of that range, 73.8% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — PULM slides 3.5% to $1.38, a 1-month low, 3 down days in a row
- Closed at $1.38, -3.50% vs the prior close of $1.43. Day range $1.36–$1.42, opened at $1.40.
- Volume was 32.80K shares, 1.3x its 50-day average of 25.98K.
- Price is -9.5% vs its 50-day average ($1.52) and -21.8% vs its 200-day average ($1.77).
- 52-week range $1.16–$5.24; today's close sits at 5% of that range, 73.6% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — PULM dips 2.1% to $1.43
- Closed at $1.43, -2.05% vs the prior close of $1.46. Day range $1.42–$1.51, opened at $1.47.
- Volume was 8.60K shares, 0.3x its 50-day average of 26.14K — lighter than usual.
- Price is -6.6% vs its 50-day average ($1.53) and -19.2% vs its 200-day average ($1.77).
- 52-week range $1.16–$5.24; today's close sits at 7% of that range, 72.7% below the 52-week high.
Oct 9, 2026 — PULM slides 4.4% to $1.46
- Closed at $1.46, -4.39% vs the prior close of $1.53. Day range $1.43–$1.48, opened at $1.47.
- Volume was 4.40K shares, 0.2x its 50-day average of 26.28K — lighter than usual.
- Price is -5.1% vs its 50-day average ($1.54) and -17.7% vs its 200-day average ($1.77).
- 52-week range $1.16–$5.24; today's close sits at 7% of that range, 72.1% below the 52-week high.
Oct 8, 2026 — PULM rises 2.5% to $1.53
- Closed at $1.53, +2.48% vs the prior close of $1.49. Day range $1.42–$1.58, opened at $1.45.
- Volume was 13.10K shares, 0.5x its 50-day average of 26.37K — lighter than usual.
- Price is -1.0% vs its 50-day average ($1.54) and -14.2% vs its 200-day average ($1.78).
- 52-week range $1.16–$5.24; today's close sits at 9% of that range, 70.8% below the 52-week high.
Oct 7, 2026 — PULM jumps 4.2% to $1.49
- Closed at $1.49, +4.20% vs the prior close of $1.43. Day range $1.43–$1.51, opened at $1.46.
- Volume was 11.90K shares, 0.5x its 50-day average of 26.37K — lighter than usual.
- Price is -3.6% vs its 50-day average ($1.55) and -16.5% vs its 200-day average ($1.78).
- 52-week range $1.16–$5.24; today's close sits at 8% of that range, 71.5% below the 52-week high.
Oct 6, 2026 — PULM slides 3.4% to $1.43
- Closed at $1.43, -3.38% vs the prior close of $1.48. Day range $1.41–$1.58, opened at $1.50.
- Volume was 19.50K shares, 0.7x its 50-day average of 26.16K.
- Price is -7.7% vs its 50-day average ($1.55) and -20.3% vs its 200-day average ($1.79).
- 52-week range $1.16–$5.50; today's close sits at 6% of that range, 74.0% below the 52-week high.
Oct 5, 2026 — PULM slides 5.7% to $1.48
- Closed at $1.48, -5.73% vs the prior close of $1.57. Day range $1.45–$1.59, opened at $1.55.
- Volume was 24.10K shares, 0.9x its 50-day average of 25.98K.
- Price is -4.8% vs its 50-day average ($1.56) and -18.1% vs its 200-day average ($1.81).
- 52-week range $1.16–$5.50; today's close sits at 7% of that range, 73.1% below the 52-week high.
Oct 2, 2026 — PULM rises 1.9% to $1.57
- Closed at $1.57, +1.95% vs the prior close of $1.54. Day range $1.48–$1.60, opened at $1.59.
- Volume was 15.30K shares, 0.6x its 50-day average of 26.09K — lighter than usual.
- Price is +0.7% vs its 50-day average ($1.56) and -13.8% vs its 200-day average ($1.82).
- 52-week range $1.16–$5.50; today's close sits at 9% of that range, 71.4% below the 52-week high.
PULM latest news & SEC filings
Every SEC filing by or about PULM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 7, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Oct 5, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Sep 25, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Sep 25, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 25, 2026 · Form DEFM14A — DEFM14A filing
DEFM14A filing
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$1.04M (prior year -$1.55M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.29 (prior year -$0.42) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade PULM
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 15, 2026, Feb 26, 2026, Oct 16, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.25% (largest 16.7%). That is a volatile stock.
- Liquidity: about 32.91K shares (≈$44.76K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.36 vs a range of $1.16–$5.24 (5% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-Q Aug 13, 2026; 8-K Aug 13, 2026; 10-Q May 15, 2026.
- Share count: 3.65M shares outstanding (Aug 13, 2026), +0.0% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
PULM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.42 | 1.48 | 1.35 | 1.36 | 14.39K |
| Oct 15, 2026 | 1.36 | 1.49 | 1.34 | 1.41 | 22.10K |
| Oct 14, 2026 | 1.36 | 1.39 | 1.35 | 1.37 | 10.00K |
| Oct 13, 2026 | 1.40 | 1.42 | 1.36 | 1.38 | 32.80K |
| Oct 12, 2026 | 1.47 | 1.51 | 1.42 | 1.43 | 8.60K |
| Oct 9, 2026 | 1.47 | 1.48 | 1.43 | 1.46 | 4.40K |
| Oct 8, 2026 | 1.45 | 1.58 | 1.42 | 1.53 | 13.10K |
| Oct 7, 2026 | 1.46 | 1.51 | 1.43 | 1.49 | 11.90K |
| Oct 6, 2026 | 1.50 | 1.58 | 1.41 | 1.43 | 19.50K |
| Oct 5, 2026 | 1.55 | 1.59 | 1.45 | 1.48 | 24.10K |
| Oct 2, 2026 | 1.59 | 1.60 | 1.48 | 1.57 | 15.30K |
| Oct 1, 2026 | 1.54 | 1.55 | 1.50 | 1.54 | 7.90K |
| Sep 30, 2026 | 1.54 | 1.58 | 1.50 | 1.52 | 8.40K |
| Sep 29, 2026 | 1.59 | 1.63 | 1.55 | 1.56 | 7.40K |
| Sep 28, 2026 | 1.68 | 1.68 | 1.54 | 1.59 | 40.10K |
| Sep 25, 2026 | 1.64 | 1.70 | 1.60 | 1.61 | 11.90K |
| Sep 24, 2026 | 1.68 | 1.72 | 1.66 | 1.67 | 14.30K |
| Sep 23, 2026 | 1.72 | 1.75 | 1.65 | 1.68 | 29.50K |
| Sep 22, 2026 | 1.77 | 1.78 | 1.64 | 1.70 | 113.00K |
| Sep 21, 2026 | 1.39 | 1.68 | 1.39 | 1.68 | 249.50K |
About Pulmatrix
Pulmatrix (PULM) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in FRAMINGHAM, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1574235.
PULM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
PULM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-5.16M | -1.41 | $-5.43M |
| Dec 31, 2024 | $7.81M | $-9.56M | -2.62 | $-10.72M |
| Dec 31, 2023 | $7.30M | $-14.12M | -3.87 | $-15.98M |
| Dec 31, 2022 | $6.07M | $-18.84M | -5.46 | $-19.36M |
| Dec 31, 2021 | $5.17M | $-20.17M | — | $-19.73M |
Latest balance sheet: total assets $3.25M, total liabilities $689.00K, cash $2.17M (as of Jun 30, 2026).
PULM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $1.51 |
| May 15, 2026 | 8-K Item 2.02 (results) | $1.25 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $2.91 |
| Oct 16, 2025 | 8-K Item 2.02 (results) | $4.64 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $5.31 |
| Mar 21, 2025 | 8-K Item 2.02 (results) | $7.47 |
| Nov 8, 2024 | 8-K Item 2.02 (results) | $2.05 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
| May 10, 2024 | 8-K Item 2.02 (results) | — |
| Mar 28, 2024 | 8-K Item 2.02 (results) | — |
| Jan 8, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PULM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.